<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4793">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01816802</url>
  </required_header>
  <id_info>
    <org_study_id>2012-AUX-009</org_study_id>
    <secondary_id>TST 2193-p</secondary_id>
    <nct_id>NCT01816802</nct_id>
  </id_info>
  <brief_title>Registry Study of Traditional Morphology Grading Combined With Eeva in IVF Treatment</brief_title>
  <acronym>MERGE</acronym>
  <official_title>MERGE: MulticEnter ReGistry With Eeva</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Auxogyn, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Auxogyn, Inc.</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to record and evaluate the use of traditional morphology
      grading combined with Eeva in the treatment of in vitro fertilization.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, observational, single-arm, nonrandomized, multicenter study.  Data
      will be collected to establish eligibility, at baseline, during the stimulation and in vitro
      fertilization process, during embryo culture, at embryo transfer, at 12-18 days post egg
      retrieval to verify biochemical pregnancy, and then typically at 5-6 weeks gestational weeks
      to verify clinical pregnancy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Clinical Pregnancy Rate</measure>
    <time_frame>5-6 gestational weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Determined by first pregnancy ultrasound outcome and optional 12-month phone follow-up</description>
  </primary_outcome>
  <other_outcome>
    <measure>Multiple Pregnancy Rate</measure>
    <time_frame>5-6 gestational weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Determined by follow-up pregnancy ultrasound outcome</description>
  </other_outcome>
  <other_outcome>
    <measure>Spontaneous Miscarriage Rate</measure>
    <time_frame>5-6 gestational weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Determined by follow-up pregnancy ultrasound outcome</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>In-vitro fertilization using Eeva</arm_group_label>
    <description>Patients undergoing in-vitro fertilization treatment who provide informed consent and use Eeva in their treatment cycle.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>In-vitro fertilization using Eeva</intervention_name>
    <description>Eeva will image embryos through cleavage stage (Day 3). Embryologists will use Eeva results along with traditional morphological grading to assist in selecting embryo(s) for transfer or freezing.</description>
    <arm_group_label>In-vitro fertilization using Eeva</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing in vitro fertilization treatment who provide informed consent and use
        Eeva in their treatment cycle.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women undergoing fresh in vitro fertilization treatment using their own eggs or donor
             eggs.

        Exclusion Criteria:

          -  history of cancer.

          -  gestational carrier.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shehua Shen, MD</last_name>
    <role>Study Director</role>
    <affiliation>Auxogyn, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tasha Kalista</last_name>
    <phone>(650) 931-6732</phone>
    <email>tkalista@auxogyn.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>HRC Fertility</name>
      <address>
        <city>Encino</city>
        <state>California</state>
        <zip>91436</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gavin Anthony</last_name>
      <phone>818-788-7288</phone>
      <phone_ext>244</phone_ext>
      <email>gavin@californiareproductiveservices.com</email>
    </contact>
    <investigator>
      <last_name>Michael Feinmann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford Fertility and Reproductive Medicine Center</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mariluz Suarez, MSC</last_name>
      <email>masuarez@stanfordmed.org</email>
    </contact>
    <investigator>
      <last_name>Valerie Baker, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Reproductive Partners</name>
      <address>
        <city>Redondo Beach</city>
        <state>California</state>
        <zip>90277</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bill Yee, MD</last_name>
      <phone>310-318-3010</phone>
    </contact>
    <investigator>
      <last_name>Bill Yee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pacific Fertility Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>95124</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kirstin MacDougall</last_name>
      <phone>415-249-3638</phone>
      <email>dougall@pacificfertility.com</email>
    </contact>
    <investigator>
      <last_name>Philip Chenette, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Center for Advanced Reproductive Services (UCHC)</name>
      <address>
        <city>Farmington</city>
        <state>Connecticut</state>
        <zip>06030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Verrastro</last_name>
      <phone>860-679-4580</phone>
      <email>verrastro@adp.uchc.edu</email>
    </contact>
    <investigator>
      <last_name>Claudio Benadiva, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwestern Medical Faculty Foundation</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jared Robins, MD</last_name>
      <phone>312-695-7269</phone>
    </contact>
    <investigator>
      <last_name>Jared Robins, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fertility Centers of Illinois (River North)</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sue Jasulaitis, RN</last_name>
      <phone>312-222-8200</phone>
      <phone_ext>23413</phone_ext>
      <email>sue.jasulaitis@integramed.com</email>
    </contact>
    <investigator>
      <last_name>John Rapisarda, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fertility Centers of Illinois, Highland Park IVF Center</name>
      <address>
        <city>Highland Park</city>
        <state>Illinois</state>
        <zip>60035</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sue Jasulaitis, RN</last_name>
      <phone>312-222-8200</phone>
      <phone_ext>23413</phone_ext>
      <email>sue.jasulaitis@integramed.com</email>
    </contact>
    <investigator>
      <last_name>Angeline Beltsos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Long Island IVF</name>
      <address>
        <city>Melville</city>
        <state>New York</state>
        <zip>11747</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gail Nee, NP</last_name>
      <phone>631-768-8797</phone>
      <email>gailn@longislandivf.com</email>
    </contact>
    <investigator>
      <last_name>Daniel Kenigsberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Fertility Center</name>
      <address>
        <city>Beachwood</city>
        <state>Ohio</state>
        <zip>44122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Goldfarb, MD</last_name>
      <phone>216-285-5028</phone>
    </contact>
    <investigator>
      <last_name>James Goldfarb, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institute for Reproductive Health</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45209</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lizzie West, RN</last_name>
      <phone>513-924-5577</phone>
      <email>lizziewest@fuse.net</email>
    </contact>
    <investigator>
      <last_name>Michael Scheiber, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fertility Center of San Antonio</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Galindo</last_name>
      <phone>210-692-0577</phone>
      <email>laboffice@fertilitysa.com</email>
    </contact>
    <investigator>
      <last_name>Joesph Martin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.auxogyn.com</url>
    <description>Auxogyn, Inc. website</description>
  </link>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 3, 2014</lastchanged_date>
  <firstreceived_date>March 20, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>In vitro fertilization</keyword>
  <keyword>Assisted reproductive therapy</keyword>
  <keyword>Time-lapse image recording</keyword>
  <keyword>Image analysis software</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
